Conserved Regulatory DNA Methylation in Human and MYC/PI3K-Driven Murine EBV-Negative Burkitt Lymphoma
5 affiliations
- 1Institute of Human Genetics, Ulm University and Ulm University Medical Center, 89081 Ulm, Germany
- 2German Cancer Research Center (DKFZ) Heidelberg, Division Adaptive Immunity and Lymphoma, 69120 Heidelberg, Germany
- 3Comprehensive Cancer Center (CCC) Mecklenburg-Vorpommern, University Medicine Greifswald, 17489 Greifswald, Germany
- 4German Center for Child and Adolescent Health (DZKJ), Partner Site Ulm, 89081 Ulm, Germany
- 5Center for Rare Diseases (ZSE) Ulm, Ulm University and Ulm University Medical Center, 89081 Ulm, Germany
Abstract
Background/Objectives: Burkitt lymphoma (BL) is an aggressive germinal center B-cell (gcBC) malignancy driven by MYC deregulation and cooperating molecular alterations. A mouse model combining constitutive MYC and PI3K activity in gcBC closely recapitulates key features of human BL, but its epigenetic similarity to the human disease has not been investigated in detail. Here, we compared genome-wide DNA methylation patterns between human sporadic EBV-negative BL and this murine model. Methods: DNA methylation profiles of 37 human BL samples and 20 gcBC controls were compared with those of 8 murine tumors from the MYC/PI3K driven mouse model and 11 murine gcBC controls using Illumina methylation arrays. Differentially methylated CpGs were identified using linear modeling, and chromatin-state enrichment, cross-species gene overlap, protein interaction, and pathway enrichment analyses were performed. Results: BL showed global DNA hypomethylation in both species and distinct methylation profiles from gcBCs. CpGs hypomethylated in BL were enriched at enhancers, whereas hypermethylated CpGs were strongly enriched at poised promoters. We identified 695 genes with shared hypermethylation and 512 with shared hypomethylation between human and murine BL. Restricting the analysis to regulatory regions identified 86 genes consistently hypomethylated in both species. These genes were significantly enriched for regulation of intracellular signal transduction and sphingolipid signaling. Included are regulators of GTPase and kinase signaling, such as GNA13, RASA3, RASAL1, SPRED2, PIK3R2, PRKCA, PRKCE, and FYN. The conserved set also contained genes with established roles in germinal center B-cell biology, including FOXO1, BACH2, and NR3C1. Conclusions: Human and murine BL share conserved regulatory DNA methylation features, supporting the MYC/PI3K mouse model as a system to study epigenetic mechanisms of BL.
Related
- Adjuvant selection and optimization in the design of an epstein–barr virus–based multi-epitope vaccine against Burkitt lymphoma
- Simultaneous X-chromosome inactivation and tissue-/cell-type-specific DNA methylation in the transcriptional regulatory region of the X-linked recessive disease gene OTC.
- The HELLS–MCM5 axis coordinates transcription–replication dynamics to preserve genomic integrity in ALK-negative anaplastic large cell lymphoma
- Tissue-specific moderate DNA methylation alterations featuring hypomethylation in microRNA regulatory regions associated with advanced carotid atherosclerosis
- Histone H3K27 methylation states are sequentially catalyzed in cycling cells
BibTeX
@article{glaser2026conserved,
title = {{Conserved Regulatory DNA Methylation in Human and MYC/PI3K-Driven Murine EBV-Negative Burkitt Lymphoma}},
author = {Selina Glaser and Meiqi Ren and Sandrine Sander and Reiner Siebert},
journal = {Cancers},
year = {2026},
month = oct,
doi = {10.3390/cancers18203408},
url = {https://www.mdpi.com/2072-6694/18/20/3408},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Conserved Regulatory DNA Methylation in Human and MYC/PI3K-Driven Murine EBV-Negative Burkitt Lymphoma
AU - Selina Glaser
AU - Meiqi Ren
AU - Sandrine Sander
AU - Reiner Siebert
PY - 2026
DA - 2026/10/01
JO - Cancers
DO - 10.3390/cancers18203408
UR - https://www.mdpi.com/2072-6694/18/20/3408
AB - Background/Objectives: Burkitt lymphoma (BL) is an aggressive germinal center B-cell (gcBC) malignancy driven by MYC deregulation and cooperating molecular alterations. A mouse model combining constitutive MYC and PI3K activity in gcBC closely recapitulates key features of human BL, but its epigenetic similarity to the human disease has not been investigated in detail. Here, we compared genome-wide DNA methylation patterns between human sporadic EBV-negative BL and this murine model. Methods: DNA methylation profiles of 37 human BL samples and 20 gcBC controls were compared with those of 8 murine tumors from the MYC/PI3K driven mouse model and 11 murine gcBC controls using Illumina methylation arrays. Differentially methylated CpGs were identified using linear modeling, and chromatin-state enrichment, cross-species gene overlap, protein interaction, and pathway enrichment analyses were performed. Results: BL showed global DNA hypomethylation in both species and distinct methylation profiles from gcBCs. CpGs hypomethylated in BL were enriched at enhancers, whereas hypermethylated CpGs were strongly enriched at poised promoters. We identified 695 genes with shared hypermethylation and 512 with shared hypomethylation between human and murine BL. Restricting the analysis to regulatory regions identified 86 genes consistently hypomethylated in both species. These genes were significantly enriched for regulation of intracellular signal transduction and sphingolipid signaling. Included are regulators of GTPase and kinase signaling, such as GNA13, RASA3, RASAL1, SPRED2, PIK3R2, PRKCA, PRKCE, and FYN. The conserved set also contained genes with established roles in germinal center B-cell biology, including FOXO1, BACH2, and NR3C1. Conclusions: Human and murine BL share conserved regulatory DNA methylation features, supporting the MYC/PI3K mouse model as a system to study epigenetic mechanisms of BL.
SN - 2072-6694
ER -